Klein Matthew B.

Klein Matthew B. is listed in filings as Director at ClearPoint Neuro, Inc.. This profile follows SEC Form 4 activity through May 26, 2026, including sale activity. Recent filings connect the profile to ClearPoint Neuro, Inc. (CLPT) and PTC Therapeutics, Inc. (PTCT). The current snapshot covers public activity from May 19, 2025 to May 26, 2026. Reported amounts are shown as $185.4K to $186.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.